Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1234.60
-10.90 (-0.88%) Dr. Reddy's Lab - Quaterly Results
Date: 28-01-2022
A minor change in the total revenue was seen in the December 2021 quarter. The total revenue for the quarter stood at Rs. 34796.00 millions against Rs. 34082.00 millions during year ago period.The Company's Net profit for the December 2021 quarter have declined marginally to Rs. 3411.00 millions as against Rs. 4437.00 millions reported during the corresponding quarter ended.The company reported a degrowth in operating Profit to 6770.00 millions from 8368.00 millions.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202112 | 202012 | % Var | 202112 | 202012 | % Var | 202103 | 202003 | % Var | |
| Sales | 34796.00 | 34082.00 | 2.09 | 107365.00 | 99984.00 | 7.38 | 133491.00 | 118504.00 | 12.65 |
| Other Income | 630.00 | 628.00 | 0.32 | 3673.00 | 7341.00 | -49.97 | 8011.00 | 7432.00 | 7.79 |
| PBIDT | 6770.00 | 8368.00 | -19.10 | 22915.00 | 32534.00 | -29.57 | 39379.00 | 36128.00 | 9.00 |
| Interest | 77.00 | 65.00 | 18.46 | 253.00 | 298.00 | -15.10 | 467.00 | 478.00 | -2.30 |
| PBDT | 6693.00 | 8303.00 | -19.39 | 22662.00 | 32236.00 | -29.70 | 38912.00 | 35650.00 | 9.15 |
| Depreciation | 2054.00 | 2124.00 | -3.30 | 6091.00 | 6243.00 | -2.43 | 8350.00 | 7892.00 | 5.80 |
| PBT | 4639.00 | 6179.00 | -24.92 | 16571.00 | 25993.00 | -36.25 | 30562.00 | 27758.00 | 10.10 |
| TAX | 1228.00 | 1742.00 | -29.51 | 4536.00 | 7244.00 | -37.38 | 8698.00 | -1619.00 | -637.25 |
| Deferred Tax | 416.00 | 634.00 | -34.38 | 1584.00 | 2631.00 | -39.79 | 3297.00 | -6458.00 | -151.05 |
| PAT | 3411.00 | 4437.00 | -23.12 | 12035.00 | 18749.00 | -35.81 | 21864.00 | 29377.00 | -25.57 |
| Equity | 832.00 | 831.00 | 0.12 | 832.00 | 831.00 | 0.12 | 832.00 | 831.00 | 0.12 |
| PBIDTM(%) | 19.46 | 24.55 | -20.76 | 21.34 | 32.54 | -34.41 | 29.50 | 30.49 | -3.24 |